Education and Resources

At IntimMedicine, we put education at the forefront of our practice. We are both medical providers and sexual health educators. We provide a safe and supportive space to discuss your health, a comfortable atmosphere to ask us questions, and diverse resources for understanding your body.

Education

Publications

Dr. Simon is an established researcher and author--completing more than 450 research trials, and more than 800 published guidelines, articles, abstracts, chapters, and the paperback book: Restore Yourself: A Woman’s Guide to Reviving Her Sexual Desire and Passion for Life.

Here is a short list of Dr. Simon’s publications on testosterone’s uses in women.

Original Testosterone Papers in Refereed Journals

  1. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine (NEJM). 343 (10); 682-688. September 7, 2000.
  2. Simon JA, Mazer NA, Wekselman K. Safety profile: transdermal testosterone treatment of women after oophorectomy. Obstetrics & Gynecology. 97 (4); S10-1. 2001.
  3. Simon JA. Emerging treatment strategies for hypoactive sexual desire disorder in postmenopausal women. Supplement to Contemporary OB/GYN: Restoring sexual desire: the safety and efficacy of testosterone in menopausal women. 18-23. September 2004.
  4. Simon JA, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder: results of the intimate SM1 Study. Journal of Clinical Endocrinology and Metabolism (JECM). 90 (9); 52265233. 2005.
  5. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Archives of Internal Medicine. 165 (14); 1582-1589. July 25, 2005.
  6. Shifren JL, Davis SR, Dennerstein L, Heiman JR, Lobo RA, Simon JA. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society (NAMS). Menopause. 12 (5); 497-511. November 2005.
  7. Simon JA. The role of testosterone in the treatment of hypoactive sexual desire disorder in postmenopausal women. Menopause Management. 14 (6); 6-11. November-December 2005.
  8. Traish A, Guay A, Spark F, Simon JA, the Testosterone Therapy in Women Study Group. Are the Endocrine Society's clinical practice guidelines on androgen therapy in women misguided? A commentary. Journal of Sexual Medicine. 4 (5); 1223-1235. September 2007.
  9. Abdallah RT, Simon JA. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. International Journal of Impotence Research. 19 (5); 458–463. Review. September-October 2007.
  10. Traish A, Guay AT, Spark RF, and the Testosterone Therapy in Women Study Group. Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary. Journal of Sexual Medicine. 4 (6); 1782-1783. November 2007.
  11. Kingsberg SA, Simon, JA, Goldstein, I. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Journal of Sexual Medicine. 5 (Supplement 4); 182-193; quiz 193. Review. 2008.
  12. Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric. 11 (3); 181-191. Review. May 2008.
  13. Krapf JM and Simon JA. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas. Epub May 31, 2009. Review. 63 (3); 213-219. July 20, 2009.
  14. Zarek SM and Simon JA. Testosterone: Transdermal versus oral testosterone. British Journal of Sexual Medicine. 33 (2); 8-10. 2010.
  15. Nachtigall L, Casson P, Lucas J, Schofield V, Melson C, and Simon JA. Safety and tolerabililty of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecological Endocrinology. 27 (1); 39-48. January 2011.
  16. Krapf JM and Simon JA. A Gender-Specific Dose-Response Curve for Testosterone: Could Excessive Testosterone Limit Sexual Interaction in Women? Journal of Sexual Medicine. 8; 76. April, 2011.
  17. Krapf JM, Simon JA. A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women? [Presented in part at the International Society for the Study of Women's Sexual Health (ISSWSH) 2011 Annual Meeting, Scottsdale, AZ, February 10-13, 2011.] Menopause. DOI: 10.1097/GME.0000000000000863. 24 (4); 462-470. April 1, 2017.
  18. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Sexual Medicine, 16 (9); 1331-1337. DOI: 10.1016/j.jsxm.2019.07.012. September 2019.
  19. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. (2019) Global Consensus Position Statement on the Use of Testosterone Therapy for Women, Journal of Clinical Endocrinology and Metabolism. EPub September 2019. 104 (10) DOI: 10.1210/jc.2019-01603. 104 (10); 4660-4666. October 1, 2019.
  20. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Maturitas, Epub September 2, 2019. 128; 89-93. DOI: 10.1016/j.maturitas.2019.07.001. October 2019.
  21. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L & Wierman ME. Global Consensus Position Statement on the Use of Testosterone Therapy for Women, Climacteric, 22 (5); 429-434, DOI: 10.1080/13697137.2019.1637079, Epub September 2, 2019. Correction: DOI: 10.1080/13697137.2019.1673555. 22 (6); 637. October 15, 2019.
  22. Rowen TS, Davis SR, Parish S, Simon J, Vignozzi L. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women. The Journal of Sexual Medicine. 17(4); 585-594. February 13, 2020.
  23. Simon JA & Kapner MD. The Saga of Testosterone for Menopausal Women at the Food and Drug Administration (FDA). The Journal of Sexual. Medicine. 17(4); 826-829. April 1, 2020.
  24. Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Climacteric: The Journal of Adult Women’s Health and Medicine. 24(6); 533-550. April 1, 2021.
  25. Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. The Journal of Sexual Medicine. 18(5); 849-867. April 1, 2021.
  26. Laing AJ, Newson L, Simon J. Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal. 28(3); 196-203. May 6, 2022.
  27. Simon JA, Ohleth K. Testosterone for Treating Female Sexual Dysfunction. Clinical Obstetrics and Gynecology. December 18, 2024.
  28. Paschou SA, Athanasiadou KI, Hafford-Letchfield T, Hinchliff S, Mauskar M, Rees M, Simon JA, Armeni E, Erel CT, Fistonic I, Hillard T, Hirschberg AL, Meczekalski B, Mendoza N, Mueck AO, Simoncini T, Stute P, van Dijken D, Lambrinoudaki I. Sexual health and wellbeing and the menopause: An EMAS clinical guide. Maturitas. 2024 Sep 2;189:108055. doi: 10.1016/j.maturitas.2024.108055. Epub ahead of print. PMID: 39226624.

Books, Chapters, Proceedings And Invited Articles

  1. James A. Simon and Victoria Houston, Restore Yourself: A Woman's Guide to Reviving Her Sexual Desire and Passion for Life (New York: Berkley Trade, 2001).
  2. Villaseca P, Simon JA. Androgenos En Climaterio y Menopausia en el Siglo XXI [Translated: Female Sexual Dysfunction and Testosterone therapy: Essentials for Gynecologists.] Capitulo VIII; 257-261 ISBN 978-956-7992-11-9. 2011.
  3. Simon JA. A patient requests your advice about testosterone from a compounding pharmacy to supplement her hormone therapy. How should you advise her? Are there any guidelines for dosing testosterone ordered from these pharmacies? Menopause e-Consult. 9 (1); 1-2. January 2013.
  4. Pollycove R, Simon, J. Female Sexual Dysfunction and Testosterone Therapy: Essentials for Gynecologists. Androgens in Gynecological Practice: Managing the Basics. Leo Plouffe, Jr. MD and Botros Rizk, MD (eds), Cambridge University Press, 38-54. 2015.
  5. Karram M, Glaser R, Simon J, Streicher L. Testosterone supplementation in women: When, why, and how. A Supplement to OBG Management. 33(3); 32-38. March 2021.
  6. Rowen, T. S., & Simon, J. A. (2023). Sexual dysfunction in the female. In R. P. Robertson (Ed.), DeGroot's endocrinology: Basic science and clinical practice (8th ed., Chapter 128). Elsevier.